差异表达的miR-223对胃癌细胞增殖、迁移功能的影响及其机制研究
[Abstract]:Background Gastric cancer is one of the most common malignant tumors in the world. In Asia, Japan, South Korea and our country are the high-risk areas of the stomach cancer, and about 400,000 new cases in our country each year, accounting for 42% of the total number of cases in the world. The 5-year survival rate of the patients with early gastric cancer can reach more than 90%, but most of the gastric cancer is in the progress of the diagnosis, or the tumor metastasis has occurred, and the 5-year survival rate is less than 30%. To reduce the mortality of gastric cancer, the most effective measure is the early detection and early treatment, the development of molecular biology provides the advanced technical means and methodology for the research of the gastric cancer mechanism, and has important guiding significance for the development of the gastric cancer treatment plan. The miRNA is a conserved non-coding small-molecule RNA of about 18-22 nucleotides, and the miRNA regulates the expression of the protein-encoding gene at the post-transcriptional or post-transcriptional level: the m-RNA is degraded or suppressed by a non-fully complementary or nearly completely complementary combination with the target gene m RNA. Since miRNAs have been found, many studies have reported the abnormal expression of miRNAs in tumor tissues, and confirmed that miRNAs have a significant correlation with some of the cancer-inhibiting factors and the cancer-promoting factors. Objective To study the correlation between the expression level and the tumor size, TNM stage and the correlation between the tumor size and TNM stage by detecting the expression of the differentially expressed miRNA in the cancer tissue and the adjacent tissue of the gastric cancer. Bioinformatics is used to predict the target gene which is the most relevant to the invasion and metastasis of gastric cancer, and how to influence the proliferation and invasion ability of gastric cancer cells through the target gene. Methods (1) In this study,3 samples of gastric cancer and non-cancerous tissue were tested, and the expression levels of 27 miRNAs screened by the previous step were verified by the q-RT-PCR method. (2) In order to explore the relationship between the development of miRNA and gastric cancer, the expression of miR-223, miR-20a and miR-150 in the sample of gastric cancer with metastasis and metastasis and the survival condition of the patient were analyzed. The expression of miR-223,-20a and-150 in 84 cases of metastatic gastric cancer and 48 non-metastatic gastric cancer samples was detected by real-time fluorescence quantitative PCR. (3) To detect the effect of miR-223 on the proliferation of gastric cancer cells, GT3TKB and MKN45 were used as the research object. First, the level of expression of miR-223 in the original GT3TKB and MKN45 was determined. The mimetics of the chemically synthesized miR-223 and the inhibitor RNA were subsequently transfected into the GT3TKB and the MKN45 cell lines, respectively. Secondly, the transwell-cell invasion experiment and the scratch-healing experiment were performed on the transfected cells. (4) In order to find the target gene of the miRNA-223, the target gene PAX6 with the largest correlation with the invasion and metastasis of the gastric cancer was selected by means of bioinformatics and according to the experience rules and the published research results. The expression level of PAX6 was detected by RT-PCR and the expression of PAX6 was detected by Western blot. The expression levels of miR-223 and PAX6 in 132 patients with gastric cancer were detected by the method of q-RT-PCR and Western blot. Results (1) The screening of differentially expressed miRNAs in gastric cancer cells showed that the expression of 13 miRNAs in gastric cancer was up-regulated and 14 miRNAs were down-regulated in gastric cancer tissues. Further validation found that 21 miRNAs were in line with the results of the chip test. Among them,10 of them were highly expressed in gastric cancer tissues and 11 were low-expression in gastric cancer tissues. The expression of 6 miRNAs was not statistically significant in gastric cancer and adjacent tissues. Among them, the most significant three miRNAs were miR-223, miR-20a and miR-150, respectively. (2) The expression of the abnormal expression of the miRNA in the tissue of the gastric cancer with metastasis and the survival analysis of the patient: The results showed that the expression of miR-223 was significantly correlated with the size of the tumor and the TNM stage (P0.05). The correlation between the expression of the miR-223 and the metastasis was very significant (P0.01), and the miR-20a was significantly related to the TNM stage (P0.05). The correlation between miR-150 and TNM was significant (P 0.01), and the correlation between miR-150 and TNM was significant (P0.05). The miR-223 expression level of 76 gastric cancer samples with severe histological characteristics was then analyzed, and the correlation between the miR-223 and the survival rate of these samples was analyzed using the Kaplan-Meier survival analysis, and the results showed that the disease-free survival rate of the miR-223 low-expression group was significantly higher than that of the miR-223 high-expression group. These results show that the expression of miR-223 is related to the development of gastric cancer. (3) The study of the effect of miR-223 on the migration and invasion of gastric cancer cells: The expression of miR-223 of MKN45 with high invasiveness was significantly up-regulated than that of GT3TKB (P0.01). The proliferation activity of MKN45 on day 3 after transfection of an inhitor of miR-223 was reduced. The expression of the endogenous miR-223 of the GT3TKB was up-regulated by transfection of miR-223 misitics, and under the same multiple microscope, we observed that the GT3TKB cells transfected with mimics, which passed through the matrix of the invasion cell, were more dense and the number of GT3TKB cells in the control group (150:100; p0.01), suggesting an increase in the invasion ability. On the contrary, after the miR-223 expression of MKN45 was down-regulated by miR-223 inhitor, the number of cells that passed through the matrix gel was less than that of the control group (150:200; p0.05), indicating a decrease in the invasion force. After 1 day after transfection of the GT3TKB of miR-223 misitics, the scratch-healing condition was better than that of the control group, which indicated that miR-223 increased the scratch-healing speed of the GT3TKB, that is, the transfer capacity; on the contrary, the MKN45 transfected with the miR-223 inhitor was significantly worse than the control group after 1 day of culture, It is shown that miR-223 plays an important role in the scratch healing of MKN45. (4) The molecular mechanism of miR-223 to promote the migration and invasion of gastric cancer cells showed that the expression of PAX6 of the GT3TKB cell line transfected with miR-223mmics was significantly lower than that of the untransfected GT3TKB control group. The expression of PAX6 in the MKN45 cell line transfected with miR-223 inhitor was higher than that of the control group (MKN45). Conclusion (1) There are 21 miRNAs differentially expressed in gastric cancer, and the most significant miRNAs are miR-223, miR-20a and miR-150. (2) The expression level of miR-223 was significantly correlated with tumor size and TNM stage, and the correlation between miR-20a and TNM was very significant, and the correlation between miR-20a and TNM was very significant; and miR-150 was associated with TNM stage only. Further analysis showed that the high expression of miR-223 was related to the severity of the histological character and the low survival rate. (3) miR-223 can promote the proliferation of gastric cancer cells and promote the invasion and metastasis of gastric cancer cells. (4) PAX6 is the target gene of miR-223 in gastric cancer cells. (5) The miR-223 can enhance the proliferation and the invasion ability of the gastric cancer cells by down-regulating the PAX6. Therefore, miR-223 and PAX6 may be the target for gastric cancer treatment.
【学位授予单位】:吉林大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R735.2
【相似文献】
相关期刊论文 前10条
1 戴成雨;胃癌20例误诊分析[J];实用医学杂志;2002年03期
2 李秋波,陶智慧,胡奎,韩智,马勇;胃癌术前区域动脉灌注化疗加手术联合治疗的疗效观察(附24例)[J];航空航天医药;2003年03期
3 倪海滨,毛振彪,黄介飞,肖明兵,季颖林,张彦亮,冒海蕾;血清可溶性细胞间粘附分子-1与胃癌临床意义的研究[J];南通医学院学报;2003年01期
4 邢亚莉;姚春霞;唐晓君;刘春梅;;彩超在胃癌诊断中的价值[J];基层医学论坛;2007年17期
5 ;日本专家用新技术提高胃癌诊断准确率[J];生物医学工程与临床;2009年02期
6 ;新技术能提高胃癌诊断准确率[J];中华中医药学刊;2009年07期
7 高春光;;胃癌患者的临床治疗体会[J];中国民族民间医药;2009年14期
8 高瑞凤;朱晔;刘兴姣;;37例进展期胃癌的超声分析[J];中国实用医药;2010年25期
9 姜可伟;;规范全球第二大致死率疾病的诊断——《胃癌诊断标准》解读[J];中国卫生标准管理;2010年04期
10 张常华;何裕隆;詹文华;吴英;;多学科小组与胃癌诊治[J];现代肿瘤医学;2011年06期
相关会议论文 前10条
1 武淑兰;魏志杰;殷宇明;;胃癌致微血管病性溶血性贫血的诊断[A];第十一届全国红细胞疾病学术会议暨学习班论文汇编[C];2007年
2 丁涛;;超声在诊断胃癌中的应用[A];中国超声医学工程学会第三届全国肌肉骨骼超声医学学术交流会论文汇编[C];2011年
3 陈晓康;吕国荣;苏若瑟;;应用彩色能量多普勒血流显像对胃癌的诊断价值[A];庆祝中国超声医学工程学会成立20周年——第八届全国超声医学学术会议论文汇编[C];2004年
4 于吉人;;胃癌的术前系统评估[A];2004年浙江省外科学学术年会论文汇编[C];2004年
5 杨军乐;宁文德;董季平;徐敏;;多层螺旋CT在胃癌诊断中的应用研究[A];中华医学会第十三届全国放射学大会论文汇编(下册)[C];2006年
6 张晓鹏;;胃癌磁共振成像研究进展[A];第四届中国肿瘤学术大会暨第五届海峡两岸肿瘤学术会议教育集[C];2006年
7 张丽红;常维平;黄贤会;;螺旋CT在特殊部位胃癌诊断中的应用[A];中国医师协会放射医师分会首届会员大会暨第四届医学影像山东论坛、山东省第16次放射学会议暨山东省第14届医学影像学学术研讨会论文集[C];2007年
8 陈静;;彩色多普勒超声检查在胃癌的应用[A];中国超声医学工程学会第七届全国腹部超声学术会议学术论文汇编[C];2007年
9 刘池波;梁勇;王海宝;杨林军;梁津逍;;胃癌患者中血清淀粉样蛋白A的测定及临床意义[A];第二届中国医学细胞生物学学术大会暨细胞生物学教学改革会议论文集[C];2008年
10 吴厚宾;;腹腔镜在胃癌诊治中的应用进展(综述)[A];江西省第二届胃肠外科学术会议暨江西省第十二次中西医结合普通外科学术会议论文汇编[C];2012年
相关重要报纸文章 前10条
1 钱铮;新技术能提高胃癌诊断准确率[N];中国中医药报;2009年
2 记者 陈青;胃癌患者从“存活”迈向“乐活”[N];文汇报;2010年
3 李楠;胃癌诊断敏感性从不足30%提高到57.4%[N];健康报;2008年
4 通讯员 李楠;胃癌“转化医学”研究见成效[N];上海科技报;2008年
5 记者 楚燕 通讯员 那伟 高树灼;厦门胃癌研究达国际领先水平[N];厦门日报;2009年
6 胡德荣;新型胃癌分子标志物研究获突破[N];中国医药报;2010年
7 本报记者 周芳;改善饮食习惯 早发现早治疗[N];吉林日报;2006年
8 中南大学湘雅二医院 杨燕贻;胃癌防治有哪些错误观念[N];大众卫生报;2005年
9 特约记者 程守勤;胃癌诊断又有新方法[N];家庭医生报;2003年
10 重庆万州 黄琼;胃癌的手术治疗[N];上海中医药报;2013年
相关博士学位论文 前10条
1 孙大志;基于microRNA 21的调控作用探讨从痰论治胃癌的作用机制[D];中国人民解放军医学院;2012年
2 陈悦之;TNFAIP8在胃癌中的表达和对调节胃癌细胞增殖,影响侵袭及迁移中的作用研究[D];山东大学;2015年
3 殷继鹏;肿瘤血管靶向肽GX1用于胃癌的分子影像研究[D];第四军医大学;2015年
4 蔡习强;TFEB介导的自噬在胃癌耐药中的作用及其机制研究[D];第四军医大学;2015年
5 赵晓迪;microRNA-7调控胃癌恶性生物学行为的功能与分子机制研究[D];第四军医大学;2015年
6 尚华;MicroRNA-125a在胃癌中表达水平的研究及其临床意义[D];山东大学;2015年
7 关中正;TGF-β在胃癌免疫逃逸中作用及机制研究[D];山东大学;2015年
8 黄勇;AEG-1/MT qDH、NF-κB、MMP-9在胃癌中的表达及相关性的研究[D];山东大学;2015年
9 谢黎明;胃癌中miR-124表达的意义及作用机制研究[D];南华大学;2015年
10 刘佳宁;SOX9和CEACAM1在胃癌组织中表达及其对胃癌细胞增殖和转移的影响[D];山东大学;2015年
相关硕士学位论文 前10条
1 徐海蓉;胃癌危险因素的流行病学研究[D];南京医科大学;2002年
2 张军利;p27、PTEN与VEGF蛋白在胃癌组织中的表达及其意义[D];泰山医学院;2014年
3 马春婷;胃癌与幽门螺杆菌的相关性研究[D];石河子大学;2015年
4 王士杰;腹腔镜手术治疗进展期远端胃癌的临床疗效及患者术后随访生存质量研究[D];中国人民解放军医学院;2015年
5 李浩;胃癌血清蛋白标记物的筛选与鉴定[D];郑州大学;2015年
6 王巍;胃癌患者血液样品的光谱分析[D];郑州大学;2015年
7 李玉博;高场磁共振在胃癌术前T分期与分级的价值[D];郑州大学;2015年
8 张苏钰;SOX4和P53蛋白在胃癌组织中的表达及贞芪扶正胶囊对胃癌术后辅助治疗作用的观察[D];兰州大学;2015年
9 马来阳;能谱CT成像在胃癌术前分期及分化程度评价中的应用研究[D];兰州大学;2015年
10 侯向红;HORMAD2在胃癌中的表达及对胃癌细胞增殖和凋亡的影响[D];兰州大学;2015年
,本文编号:2484961
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2484961.html